Overview
Advate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Advate can also be used for…

Overview
Adynovate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and adolescents over the age of 12 with factor VIII deficiency due to hemophilia A. Adynovate…

Overview
Afstyla is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Afstyla can also be used for…

Overview
Alhemo is approved by the U.S. Food and Drug Administration (FDA) for the routine prophylaxis (prevention) of bleeding episodes in adults and children aged 12 years and older with hemophilia A (congenital factor…

Overview
Alphanate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Alphanate is also used in people…

Overview
AlphaNine SD is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia B. The technical name of AlphaNine SD is Coagulation factor IX factor (human)…

Overview
Alprolix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. Alprolix can also be used for perioperative (before, during, and…

Overview
Altuviiio is approved by the U.S. Food and Drug Administration (FDA) for use in adults and children with hemophilia A (congenital factor VIII deficiency). It is indicated for routine prophylaxis to reduce…

Overview
BeneFix is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with hemophilia B. BeneFix can also be used for perioperative (before, during, and…

Overview
Cyklokapron is approved by the Food and Drug Administration (FDA) for short-term use in people with hemophilia. Cyklokapron may be used for two to eight days to reduce or prevent hemorrhage during and after…

Overview
DDAVP is approved by the U.S. Food and Drug Administration (FDA) for use in people with hemophilia A who have factor VIII (8) coagulant activity levels greater than 5 percent as well as for people with von…

Overview
Eloctate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Eloctate can also be used for…

Overview
Esperoct is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in adults and children with factor VIII deficiency due to hemophilia A. Esperoct can also be used for…

Overview
Feiba is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in people with hemophilia A and B who have developed inhibitors. Feiba can also be used for perioperative (before…

Overview
Hemgenix is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with hemophilia B. To be eligible for Hemgenix, you must either currently be using factor IX (9)…

Overview
Hemlibra is approved by the Food and Drug Administration (FDA) as routine prophylaxis in children and adults with hemophilia A and factor VIII inhibitors. The technical name of Hemlibra is Emicizumab-kxwh…

Overview
Hemofil M is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in people with factor VIII deficiency due to hemophilia A. The technical name of Hemofil M is…

Overview
Humate-P is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Humate-P is also used to treat bleeding episodes and for perioperative (before, during…

Overview
Hympavzi is approved by the U.S. Food and Drug Administration (FDA) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and children 12 and up with hemophilia A (congenital…

Overview
Idelvion is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor IX deficiency due to hemophilia B. Idelvion can also be used for…

Overview
Ixinity is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults and children age 12 or older with hemophilia B. Ixinity can also be used for perioperative (before, during…

Overview
Jivi is a recombinant antihemophilic factor approved by the U.S. Food and Drug Administration (FDA) for the treatment and management of hemophilia A (congenital factor VIII [8] deficiency) in previously treated…

Overview
Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after surgery) care…

Overview
Kovaltry is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Kovaltry can also be used for…